Advanced

Carbamylation of immunoglobulin abrogates activation of the classical complement pathway

Koro, Catalin; Bielecka, Ewa; Dahl-Knudsen, Anders; Enghild, Jan J.; Scavenius, Carsten; Brun, Johan G.; Binder, Veronika; Hellvard, Annelie; Bergum, Brith and Jonsson, Roland, et al. (2014) In European Journal of Immunology 44(11). p.3403-3412
Abstract
Post-translational modifications of proteins significantly affect their structure and function. The carbamylation of positively charged lysine residues to form neutral homoitrulline occurs primarily under inflammatory conditions through myeloperoxidase-dependent cyanate (CNO-) formation. We analyzed the pattern of human IgG(1) carbamylation under inflammatory conditions and the effects that this modification has on the ability of antibodies to trigger complement activation via the classical pathway. We found that the lysine residues of IgG(1) are rapidly modified after brief exposure to CNO-. Interestingly, modifications were not random, but instead limited to only few lysines within the hinge area and the N-terminal fragment of the CH2... (More)
Post-translational modifications of proteins significantly affect their structure and function. The carbamylation of positively charged lysine residues to form neutral homoitrulline occurs primarily under inflammatory conditions through myeloperoxidase-dependent cyanate (CNO-) formation. We analyzed the pattern of human IgG(1) carbamylation under inflammatory conditions and the effects that this modification has on the ability of antibodies to trigger complement activation via the classical pathway. We found that the lysine residues of IgG(1) are rapidly modified after brief exposure to CNO-. Interestingly, modifications were not random, but instead limited to only few lysines within the hinge area and the N-terminal fragment of the CH2 domain. A complement activation assay combined with mass spectrometry analysis revealed a highly significant inverse correlation between carbamylation of several key lysine residues within the hinge region and N-terminus of the CH2 domain and the proper binding of C1q to human IgG(1) followed by subsequent complement activation. This severely hindered complement-dependent cytotoxicity of therapeutic IgG(1). The reaction can apparently occur in vivo, as we found carbamylated antibodies in synovial fluid from rheumatoid arthritis patients. Taken together, our data suggest that carbamylation has a profound impact on the complement-activating ability of IgG(1) and reveals a pivotal role for previously uncharacterized lysine residues in this process. (Less)
Please use this url to cite or link to this publication:
author
, et al. (More)
(Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
Carbamylation, IgG(1), Complement, Inflammation, Rheumatoid arthritis
in
European Journal of Immunology
volume
44
issue
11
pages
3403 - 3412
publisher
John Wiley & Sons
external identifiers
  • wos:000345225000024
  • scopus:84916898715
ISSN
1521-4141
DOI
10.1002/eji.201444869
language
English
LU publication?
yes
id
ee462b71-4ea8-4d78-b119-489522765f1e (old id 4984626)
date added to LUP
2015-02-03 07:13:29
date last changed
2017-10-22 03:16:14
@article{ee462b71-4ea8-4d78-b119-489522765f1e,
  abstract     = {Post-translational modifications of proteins significantly affect their structure and function. The carbamylation of positively charged lysine residues to form neutral homoitrulline occurs primarily under inflammatory conditions through myeloperoxidase-dependent cyanate (CNO-) formation. We analyzed the pattern of human IgG(1) carbamylation under inflammatory conditions and the effects that this modification has on the ability of antibodies to trigger complement activation via the classical pathway. We found that the lysine residues of IgG(1) are rapidly modified after brief exposure to CNO-. Interestingly, modifications were not random, but instead limited to only few lysines within the hinge area and the N-terminal fragment of the CH2 domain. A complement activation assay combined with mass spectrometry analysis revealed a highly significant inverse correlation between carbamylation of several key lysine residues within the hinge region and N-terminus of the CH2 domain and the proper binding of C1q to human IgG(1) followed by subsequent complement activation. This severely hindered complement-dependent cytotoxicity of therapeutic IgG(1). The reaction can apparently occur in vivo, as we found carbamylated antibodies in synovial fluid from rheumatoid arthritis patients. Taken together, our data suggest that carbamylation has a profound impact on the complement-activating ability of IgG(1) and reveals a pivotal role for previously uncharacterized lysine residues in this process.},
  author       = {Koro, Catalin and Bielecka, Ewa and Dahl-Knudsen, Anders and Enghild, Jan J. and Scavenius, Carsten and Brun, Johan G. and Binder, Veronika and Hellvard, Annelie and Bergum, Brith and Jonsson, Roland and Potempa, Jan and Blom, Anna and Mydel, Piotr},
  issn         = {1521-4141},
  keyword      = {Carbamylation,IgG(1),Complement,Inflammation,Rheumatoid arthritis},
  language     = {eng},
  number       = {11},
  pages        = {3403--3412},
  publisher    = {John Wiley & Sons},
  series       = {European Journal of Immunology},
  title        = {Carbamylation of immunoglobulin abrogates activation of the classical complement pathway},
  url          = {http://dx.doi.org/10.1002/eji.201444869},
  volume       = {44},
  year         = {2014},
}